FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to peptides, isolated from human basic proline-rich lacrimal protein (BPLP), in particular to opiorphin, and is intended for application in manufacturing medication for treatment or prevention of such disease as obsessive-compulsive disorder, narcolepsy, hypersomnia, reduction of vigilance, deficit of attention in children, bipolar disease, dysthymic disorder and cyclothymic disorder.
EFFECT: application of group of inventions ensures application of peptides, which do not have at all or have very weak side effects.
15 cl, 3 dwg, 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL PEPTIDES WITH ANALGESIC EFFECT, INHIBITING ASIC-RFYFKS | 2011 |
|
RU2583299C2 |
| OPIORPHIN PEPTIDE DERIVATIVES AS POTENTIAL INHIBITORS OF ECTOPEPTIDASES, PARTICIPATING IN DEGRADATION OF ENKEPHALINS | 2009 |
|
RU2542365C2 |
| ANALGESIC AGENT FOR VISCERAL PAIN MANAGEMENT | 2010 |
|
RU2429874C1 |
| ANALGESIC AGENT OF PEPTIDE STRUCTURE OF UNDERCAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2541127C1 |
| PEPTIDE PREPARATION HAVING ANALGESIC ACTIVITY | 1993 |
|
RU2040272C1 |
| ANALGESIC AGENT OF PEPTIDE STRUCTURE BASED ON TRIDECAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2538727C1 |
| PEPTIDE AGENT POSSESSING ANALGESIC ANTI-INFLAMMATORY ACTION, AND BASED DOSAGE FORMS | 2012 |
|
RU2528094C2 |
| DIMERIC DIPEPTIDE MIMETIC BDNF AS AGENT FOR TREATING AND PREVENTING OPIOID ADDICTION | 2023 |
|
RU2823374C1 |
| MEANS FOR EFFECTIVE CUPPING OF ACUTE AND/OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION | 2016 |
|
RU2622980C1 |
| 6-(3,3-DIMETHYL-3,4-DIHYDROISOCHINOLIN-1-IL) AMINOHEXANE ACID AND PHARMACEUTICAL COMPOSITION ON ITS BASIS THAT HAVE ANALGETIC ACTIVITY | 2016 |
|
RU2648445C1 |
